complete and detail study on the topic of validation used in pharmaceuticals industry and also in the learning purpose for the students in the classrooms. this ppt help a lot to the students as well as teachers to learn more on the validation topics.
Validation ensures that manufacturing systems, equipment, processes, and tests consistently produce quality products. It provides documented evidence that a process will reliably meet predetermined specifications. Validation studies are performed for analytical tests, equipment, facilities, and processes. Once validated, a system or process is expected to remain in control if unchanged; revalidation is required after modifications. Validation can be prospective, concurrent, retrospective, or through revalidation, and includes protocols for equipment, facilities, and manufacturing processes to demonstrate consistent performance under normal and worst-case conditions.
The document discusses pharmaceutical process validation. It defines validation as proving a process consistently produces quality products. There are three main types of validation: prospective validation done before use, retrospective using historical data, and concurrent during routine production. Validation ensures quality, reduces costs, and meets regulations. It involves qualification of facilities and equipment, then protocols to test processes over multiple batches and demonstrate control. Periodic revalidation is also required when changes are made.
The document discusses various types of quality assurance (QA) audits, including internal and external audits. It notes that the most common types of audits in the food industry are for product manufacturing, plant sanitation/GMP, product quality, and HACCP. Special audits may also be conducted on areas like QC programs, temperature controls, or batching practices. QA documentation includes standard operating procedures (SOPs), a quality manual, and other documents describing manufacturing and quality processes. Sanitation standard operating procedures (SSOPs) provide step-by-step instructions for cleaning areas and equipment in a food plant.
009 what are the systems validation protocol methods at atl 05 28-2015atlmarketing
If your product must meet the requirements of FDA cGMP, 21 CFR 210, 211, 820, ISO-9000, ISO-13485, or MDD/93/42/EEC (for the CE Mark), there are three very critical elements you must have to be in regulatory compliance. First, you must have a sound and strong Quality Management System (QMS). This is an expression of WHAT you do (your quality policies and structure). Second, you must have reliable Standard Operating Procedures (SOP’s). These are expressions of HOW YOU DO THINGS.
Missing in the above two items is an expression of HOW WELL YOU DO WHAT YOU DO? This is where you must establish your “Systems Validation Protocol” (SVP). Your SVP is an expression of how well your system is working (for example, this can be expressed in overall product conformance percentage or in defects per million for your various products). The SVP is a living and continuous document based on your quality records. The ATL White Paper “What Are The Systems Validation Protocol Methods At ATL?” is our attempt to share with you a sound approach to Systems Validation and the various protocols that you can use.
The document discusses pharmaceutical validation, including its history, purpose, and key aspects. It provides definitions for validation, describing it as demonstrating and documenting that a process will consistently produce the expected results. The summary is as follows:
Validation aims to ensure quality is built into pharmaceutical systems and processes at every step. It includes qualification of equipment and facilities. Key parts of validation include process design, qualification, and continued verification to maintain process control. Validation is required by regulations and improves quality, efficiency and compliance for the pharmaceutical industry.
The document discusses the design, construction, commissioning, and qualification of critical utility systems for production facilities. It outlines key phases including establishing user requirement specifications, design specifications and reviews, commissioning activities, and an integrated validation approach. Critical utility systems discussed include HVAC, purified water, WFI, and CIP systems. The role of qualification in verifying system performance is also covered.
Validation, scope of validation, URS , WHO GUIDELINES FOR VALIDATIONManikant Prasad Shah
This document discusses validation, which is the process of establishing documented evidence that a system will consistently produce a product meeting its quality standards. It defines validation according to WHO and FDA and outlines the merits and scope of validation. It also discusses validation concepts like the validation master plan, V model, qualification processes for design, installation, operation and equipment, change control, and WHO guidelines for equipment validation. The types of validation covered are prospective, concurrent, retrospective and revalidation.
Validation ensures that manufacturing systems, equipment, processes, and tests consistently produce quality products. It provides documented evidence that a process will reliably meet predetermined specifications. Validation studies are performed for analytical tests, equipment, facilities, and processes. Once validated, a system or process is expected to remain in control if unchanged; revalidation is required after modifications. Validation can be prospective, concurrent, retrospective, or through revalidation, and includes protocols for equipment, facilities, and manufacturing processes to demonstrate consistent performance under normal and worst-case conditions.
The document discusses pharmaceutical process validation. It defines validation as proving a process consistently produces quality products. There are three main types of validation: prospective validation done before use, retrospective using historical data, and concurrent during routine production. Validation ensures quality, reduces costs, and meets regulations. It involves qualification of facilities and equipment, then protocols to test processes over multiple batches and demonstrate control. Periodic revalidation is also required when changes are made.
The document discusses various types of quality assurance (QA) audits, including internal and external audits. It notes that the most common types of audits in the food industry are for product manufacturing, plant sanitation/GMP, product quality, and HACCP. Special audits may also be conducted on areas like QC programs, temperature controls, or batching practices. QA documentation includes standard operating procedures (SOPs), a quality manual, and other documents describing manufacturing and quality processes. Sanitation standard operating procedures (SSOPs) provide step-by-step instructions for cleaning areas and equipment in a food plant.
009 what are the systems validation protocol methods at atl 05 28-2015atlmarketing
If your product must meet the requirements of FDA cGMP, 21 CFR 210, 211, 820, ISO-9000, ISO-13485, or MDD/93/42/EEC (for the CE Mark), there are three very critical elements you must have to be in regulatory compliance. First, you must have a sound and strong Quality Management System (QMS). This is an expression of WHAT you do (your quality policies and structure). Second, you must have reliable Standard Operating Procedures (SOP’s). These are expressions of HOW YOU DO THINGS.
Missing in the above two items is an expression of HOW WELL YOU DO WHAT YOU DO? This is where you must establish your “Systems Validation Protocol” (SVP). Your SVP is an expression of how well your system is working (for example, this can be expressed in overall product conformance percentage or in defects per million for your various products). The SVP is a living and continuous document based on your quality records. The ATL White Paper “What Are The Systems Validation Protocol Methods At ATL?” is our attempt to share with you a sound approach to Systems Validation and the various protocols that you can use.
The document discusses pharmaceutical validation, including its history, purpose, and key aspects. It provides definitions for validation, describing it as demonstrating and documenting that a process will consistently produce the expected results. The summary is as follows:
Validation aims to ensure quality is built into pharmaceutical systems and processes at every step. It includes qualification of equipment and facilities. Key parts of validation include process design, qualification, and continued verification to maintain process control. Validation is required by regulations and improves quality, efficiency and compliance for the pharmaceutical industry.
The document discusses the design, construction, commissioning, and qualification of critical utility systems for production facilities. It outlines key phases including establishing user requirement specifications, design specifications and reviews, commissioning activities, and an integrated validation approach. Critical utility systems discussed include HVAC, purified water, WFI, and CIP systems. The role of qualification in verifying system performance is also covered.
Validation, scope of validation, URS , WHO GUIDELINES FOR VALIDATIONManikant Prasad Shah
This document discusses validation, which is the process of establishing documented evidence that a system will consistently produce a product meeting its quality standards. It defines validation according to WHO and FDA and outlines the merits and scope of validation. It also discusses validation concepts like the validation master plan, V model, qualification processes for design, installation, operation and equipment, change control, and WHO guidelines for equipment validation. The types of validation covered are prospective, concurrent, retrospective and revalidation.
Sop Process validation protocol executionanjali suhag
This document outlines the standard operating procedure for executing a non-sterile process validation protocol according to Health Canada GMP regulations. It assigns responsibilities to various roles and describes the steps to run three consecutive batches, record results, investigate any deviations, propose corrective actions, and finalize a validation protocol report. The goal is to validate the manufacturing process and ensure compliance with regulatory standards.
Introduction to Pharmaceutical Validation, Scope & Merits of Validation, Validation and calibration of Master plan, Hrs ICH & WHO guidelines for calibration and validation of
equipment's, Validation of specific dosage form, Types of validation. Government regulation, Manufacturing Process Model, URS, DQ, IQ, OQ & P.Q. of facilities.
This document discusses considerations for equipment qualification when purchasing, designing, or qualifying storage units. It provides definitions of key terms related to validation and equipment qualification. The document outlines regulatory requirements for validation documentation. It discusses key validation documents including validation master plans, protocols, reports, and change control systems. Challenges in validation like inadequate specifications and planning are covered. The importance of early involvement of validation personnel and good communication for validation success is emphasized.
This document discusses the qualification of equipment used in the production of artemisinin-based combined medicines. It covers the objectives, principles, and stages of equipment qualification, including design qualification, installation qualification, operational qualification, and performance qualification. The stages of qualification ensure that equipment is suitable for its intended uses and capable of consistently meeting specifications. Qualification applies to all production and quality control equipment and must demonstrate acceptable performance under worst-case conditions. Periodic requalification is necessary to confirm continued suitability of equipment for its uses.
Quality assurance is the totality of arrangements to ensure pharmaceutical products are of the required quality. It includes in-process quality checks, validation of facilities, equipment and processes, complaint handling, and stability studies. Regulatory compliance describes conforming to rules like specifications, policies, standards or laws. For pharmaceutical products, this includes complying with requirements for approvals in countries or regions like the US, Europe, and India.
This document provides guidelines for auditing and evaluating validation documentation as part of a remediation project. It outlines key activities and items to evaluate for validation and qualification documents, including worst case scenarios, critical parameters and limits, and calibration. An example process validation list and equipment qualification list are provided. General guidelines are given for validation and qualification documentation stages and content. Qualification stages for equipment, facilities, and utilities are described, including installation, operational, and performance qualification. Types of process validation including traditional, continuous, and hybrid are briefly outlined. References for further information are listed at the end.
The document discusses validation in the pharmaceutical industry. It defines validation and outlines the need for validation to ensure quality products and regulatory compliance. It describes different types of validation including process, equipment, cleaning, and analytical method validation. Key aspects of validation covered include qualification, protocols, reports, change control, and revalidation. The document emphasizes the importance of documentation in validation.
Qualification and validation activities were taking place during Quality Week from November 14-19, 2016. Qualification proves that systems and equipment work correctly, while validation proves procedures lead to expected results. There are various types of qualification including design (DQ), installation (IQ), operational (OQ), and performance (PQ) qualification. Validation can be prospective, retrospective, or concurrent. Analyst qualification requires a minimum of two analysts to run tests in triplicate to demonstrate accuracy of 98-102%. Uncertainty encompasses variability that could be reasonably attributed to measurement results and includes components evaluated statistically or from experience.
This document provides an overview of validation requirements in the pharmaceutical industry. It begins with definitions of validation from FDA guidelines in 1987 and 2011. Validation originated in the 1970s focused on sterilization, and has now expanded to all product, process, and facility matters. Validation is required to assure quality, is a regulatory requirement, and reduces costs. The stages of validation for a product and process are outlined, including process design, process qualification, and continuous process verification. Key aspects of validation like process validation, change control, and documentation are also summarized.
The document outlines requirements and guidelines for conducting an Annual Product Review (APR). Key points include:
- An APR must be conducted annually for each commercial product to assess consistency, trends, needed changes, and revalidation. It involves multiple departments and communication between manufacturing, quality, and regulatory affairs.
- The APR scope covers manufacturing sites, affiliates, and subcontractors. It must include production statistics, deviations, complaints, recalls, changes, process validation status, trend analysis, and recommendations.
- The results are evaluated to determine if corrective or preventative actions are needed. Senior management from quality and production must approve the APR, which is then archived for audits. Checklists are
Validation sampling should exceed routine QA sampling based on the impact and risk analysis of the change. The protocol should specify the sampling, such as number of samples, locations, and statistical analysis, based on the risk.
This document discusses quality assurance and regulatory compliance for pharmaceutical products. It describes quality assurance as ensuring that products meet the requirements for their intended use. This involves following good manufacturing practices (GMP) and having systems in place for production, quality control, documentation, validation, complaint handling and stability testing. Regulatory compliance requires understanding requirements for approval in different countries or regions and compiling dossiers to register products. Together, quality assurance and regulatory compliance aim to build quality into products and ensure they meet all necessary standards and regulations.
The document discusses several auxiliary facility programs that are important components of a GMP quality system, including pest control, cleaning programs, drawing control, engineering change control, spare parts management, lubricant control, and qualification of maintenance technicians and outside contractors. It emphasizes that written procedures and documentation are required for these programs to ensure facilities and equipment are properly maintained and calibrated.
The document discusses validation and qualification processes for equipment. It defines validation as establishing scientific evidence that a process is capable of consistently delivering quality products. Qualification is considered a subset of validation and ensures equipment is installed and will perform as intended. The key stages of validation are discussed as process design, process qualification, and continued process verification. Qualification includes design qualification, installation qualification, operational qualification, and performance qualification to demonstrate equipment is suitable for its intended use.
This document outlines the procedures for calibration and qualification of a friability test apparatus. It describes cleaning and operating instructions, lists those responsible for calibration and accountability, and provides an overview of the full calibration process. The calibration procedure involves testing the apparatus at different parameter settings and time intervals to ensure it provides values within specified limits. Any deviations from the procedure are to be documented and reported, along with conclusions regarding apparatus operation.
This presentation discusses quality assurance and validation. It defines quality assurance as the totality of arrangements made to ensure pharmaceutical products are fit for their intended use. Validation is establishing evidence that a process will consistently produce products meeting specifications. The presentation covers the need for and types of validation, including validation of analytical methods, equipment, processes, cleaning, and more. It emphasizes validation is important for consistency, reliability, and producing quality products. Documentation for validation includes validation master plans, protocols, reports and standard operating procedures.
This document discusses quality assurance standards for IT systems development and operations. It states that standards provide uniform practices for system development and operation, allowing management and staff to understand requirements and assess quality. The document outlines different types of standards including development controls, performance standards, and operating standards. It notes that standards should be established, enforced as methods change, and audited to ensure documentation provides information to maintenance staff. Benefits of standards include saving time, improved management control, better system design and documentation for training and reducing individual dependence. The document also discusses user documentation contents such as system overviews, running instructions, input/output examples, and error messages.
Sop Process validation protocol executionanjali suhag
This document outlines the standard operating procedure for executing a non-sterile process validation protocol according to Health Canada GMP regulations. It assigns responsibilities to various roles and describes the steps to run three consecutive batches, record results, investigate any deviations, propose corrective actions, and finalize a validation protocol report. The goal is to validate the manufacturing process and ensure compliance with regulatory standards.
Introduction to Pharmaceutical Validation, Scope & Merits of Validation, Validation and calibration of Master plan, Hrs ICH & WHO guidelines for calibration and validation of
equipment's, Validation of specific dosage form, Types of validation. Government regulation, Manufacturing Process Model, URS, DQ, IQ, OQ & P.Q. of facilities.
This document discusses considerations for equipment qualification when purchasing, designing, or qualifying storage units. It provides definitions of key terms related to validation and equipment qualification. The document outlines regulatory requirements for validation documentation. It discusses key validation documents including validation master plans, protocols, reports, and change control systems. Challenges in validation like inadequate specifications and planning are covered. The importance of early involvement of validation personnel and good communication for validation success is emphasized.
This document discusses the qualification of equipment used in the production of artemisinin-based combined medicines. It covers the objectives, principles, and stages of equipment qualification, including design qualification, installation qualification, operational qualification, and performance qualification. The stages of qualification ensure that equipment is suitable for its intended uses and capable of consistently meeting specifications. Qualification applies to all production and quality control equipment and must demonstrate acceptable performance under worst-case conditions. Periodic requalification is necessary to confirm continued suitability of equipment for its uses.
Quality assurance is the totality of arrangements to ensure pharmaceutical products are of the required quality. It includes in-process quality checks, validation of facilities, equipment and processes, complaint handling, and stability studies. Regulatory compliance describes conforming to rules like specifications, policies, standards or laws. For pharmaceutical products, this includes complying with requirements for approvals in countries or regions like the US, Europe, and India.
This document provides guidelines for auditing and evaluating validation documentation as part of a remediation project. It outlines key activities and items to evaluate for validation and qualification documents, including worst case scenarios, critical parameters and limits, and calibration. An example process validation list and equipment qualification list are provided. General guidelines are given for validation and qualification documentation stages and content. Qualification stages for equipment, facilities, and utilities are described, including installation, operational, and performance qualification. Types of process validation including traditional, continuous, and hybrid are briefly outlined. References for further information are listed at the end.
The document discusses validation in the pharmaceutical industry. It defines validation and outlines the need for validation to ensure quality products and regulatory compliance. It describes different types of validation including process, equipment, cleaning, and analytical method validation. Key aspects of validation covered include qualification, protocols, reports, change control, and revalidation. The document emphasizes the importance of documentation in validation.
Qualification and validation activities were taking place during Quality Week from November 14-19, 2016. Qualification proves that systems and equipment work correctly, while validation proves procedures lead to expected results. There are various types of qualification including design (DQ), installation (IQ), operational (OQ), and performance (PQ) qualification. Validation can be prospective, retrospective, or concurrent. Analyst qualification requires a minimum of two analysts to run tests in triplicate to demonstrate accuracy of 98-102%. Uncertainty encompasses variability that could be reasonably attributed to measurement results and includes components evaluated statistically or from experience.
This document provides an overview of validation requirements in the pharmaceutical industry. It begins with definitions of validation from FDA guidelines in 1987 and 2011. Validation originated in the 1970s focused on sterilization, and has now expanded to all product, process, and facility matters. Validation is required to assure quality, is a regulatory requirement, and reduces costs. The stages of validation for a product and process are outlined, including process design, process qualification, and continuous process verification. Key aspects of validation like process validation, change control, and documentation are also summarized.
The document outlines requirements and guidelines for conducting an Annual Product Review (APR). Key points include:
- An APR must be conducted annually for each commercial product to assess consistency, trends, needed changes, and revalidation. It involves multiple departments and communication between manufacturing, quality, and regulatory affairs.
- The APR scope covers manufacturing sites, affiliates, and subcontractors. It must include production statistics, deviations, complaints, recalls, changes, process validation status, trend analysis, and recommendations.
- The results are evaluated to determine if corrective or preventative actions are needed. Senior management from quality and production must approve the APR, which is then archived for audits. Checklists are
Validation sampling should exceed routine QA sampling based on the impact and risk analysis of the change. The protocol should specify the sampling, such as number of samples, locations, and statistical analysis, based on the risk.
This document discusses quality assurance and regulatory compliance for pharmaceutical products. It describes quality assurance as ensuring that products meet the requirements for their intended use. This involves following good manufacturing practices (GMP) and having systems in place for production, quality control, documentation, validation, complaint handling and stability testing. Regulatory compliance requires understanding requirements for approval in different countries or regions and compiling dossiers to register products. Together, quality assurance and regulatory compliance aim to build quality into products and ensure they meet all necessary standards and regulations.
The document discusses several auxiliary facility programs that are important components of a GMP quality system, including pest control, cleaning programs, drawing control, engineering change control, spare parts management, lubricant control, and qualification of maintenance technicians and outside contractors. It emphasizes that written procedures and documentation are required for these programs to ensure facilities and equipment are properly maintained and calibrated.
The document discusses validation and qualification processes for equipment. It defines validation as establishing scientific evidence that a process is capable of consistently delivering quality products. Qualification is considered a subset of validation and ensures equipment is installed and will perform as intended. The key stages of validation are discussed as process design, process qualification, and continued process verification. Qualification includes design qualification, installation qualification, operational qualification, and performance qualification to demonstrate equipment is suitable for its intended use.
This document outlines the procedures for calibration and qualification of a friability test apparatus. It describes cleaning and operating instructions, lists those responsible for calibration and accountability, and provides an overview of the full calibration process. The calibration procedure involves testing the apparatus at different parameter settings and time intervals to ensure it provides values within specified limits. Any deviations from the procedure are to be documented and reported, along with conclusions regarding apparatus operation.
This presentation discusses quality assurance and validation. It defines quality assurance as the totality of arrangements made to ensure pharmaceutical products are fit for their intended use. Validation is establishing evidence that a process will consistently produce products meeting specifications. The presentation covers the need for and types of validation, including validation of analytical methods, equipment, processes, cleaning, and more. It emphasizes validation is important for consistency, reliability, and producing quality products. Documentation for validation includes validation master plans, protocols, reports and standard operating procedures.
This document discusses quality assurance standards for IT systems development and operations. It states that standards provide uniform practices for system development and operation, allowing management and staff to understand requirements and assess quality. The document outlines different types of standards including development controls, performance standards, and operating standards. It notes that standards should be established, enforced as methods change, and audited to ensure documentation provides information to maintenance staff. Benefits of standards include saving time, improved management control, better system design and documentation for training and reducing individual dependence. The document also discusses user documentation contents such as system overviews, running instructions, input/output examples, and error messages.
This document discusses qualification and validation in pharmaceutical manufacturing. It begins by defining validation as establishing evidence through documentation that a process will consistently produce products meeting predetermined specifications. Qualification involves establishing that equipment and systems are capable of operating within established parameters. The document outlines the types of validation documentation including validation master plans, protocols, and reports. It also discusses the different types of qualification including design, installation, operational, and performance qualification. Finally, it discusses approaches to validation including prospective, concurrent, and retrospective validation and emphasizes that validation should follow a lifecycle approach.
This document provides an overview of validation in the pharmaceutical industry. It discusses the concepts, types, elements and phases of validation including design qualification, installation qualification, operational qualification, performance qualification and process validation. Validation is required to ensure manufacturing processes are capable of consistently producing quality products and involves establishing documented evidence through qualification and monitoring activities. The document outlines the key principles and guidelines for validation as well as the roles and responsibilities of those involved.
QUALIFICATION & VALIDATION.Validation is an essential part of GMP, and an element of QA.Critical steps in the process need to be validated.Need for confidence that the product will consistently meet predetermined specifications and attributes.
The document discusses process validation, providing definitions and the purpose, types, and documentation requirements. It defines validation as establishing evidence that a process consistently produces a product meeting predetermined specifications. The main types of validation are prospective, concurrent, and retrospective. Validation aims to gain high assurance that a manufacturing process will consistently produce products meeting quality standards over time. Documentation of validation protocols, reports, and ongoing monitoring is required.
PHARMACEUTICAL CALIBRATION & VALIDATION.
What is Validation?
What is calibration?
What are the types of Validation ?
Validation and calibration Basic Difference
The document discusses validation of pharmaceutical processes. It describes the key elements of validation including design qualification, installation qualification, operational qualification and performance qualification. It discusses different types of validation such as prospective validation, concurrent validation and retrospective validation. It also discusses revalidation which is needed when any changes are made that could impact quality. The validation process involves three phases - pre-validation, process validation and validation maintenance. A validation protocol and validation master plan are developed to document the validation activities and ensure a systematic approach.
This document provides an introduction to validation in the pharmaceutical industry. It discusses the origins and need for validation to ensure quality and control costs. The document outlines the key types of validation: prospective, retrospective, concurrent and revalidation. It also describes the scope of validation, noting it requires appropriate infrastructure, documentation, personnel and management involvement. Validation should be performed for facilities, equipment, utilities, processes and when major changes occur to demonstrate consistency in producing products that meet specifications.
Process validation establishes documented evidence that a manufacturing process will consistently produce products meeting specifications. It involves qualifying facilities and equipment, validating critical process parameters, and revalidating when changes occur. Validation includes prospective validation of new processes and retrospective validation of existing stable processes by statistical analysis of historical batch data. Documentation of the validation master plan, protocols, reports, and results provide assurance that processes are properly controlled.
Validation is a documented program that provides high degree of assurance that a specific process, method or system consistently produces a result meeting pre-determined acceptance criteria.
This document discusses validation of analytical methods. It defines validation as establishing evidence that a process will consistently produce results meeting specifications. Validation guidelines include ICH Q2A, Q2B, FDA guidance, and pharmacopoeias. Key validation characteristics covered are specificity, linearity, range, accuracy, precision, detection/quantitation limits, robustness, and system suitability testing. Equipment validation involves design qualification, installation qualification, operational qualification, performance qualification, and process qualification in three phases: pre-validation, process validation, and validation maintenance.
The document provides details on developing a validation master plan, including definitions of key terms like validation, qualification, and protocols. It discusses the importance and types of validation as well as the key elements, format, and content of a validation master plan. The content includes facilities, equipment, utilities, processes to be validated, responsibilities, schedules, documentation requirements, and protocols for qualification stages.
This document discusses process validation in the pharmaceutical industry. It defines process validation and describes it as having three stages: process design, process qualification, and continued process verification. The objectives and requirements of each stage are explained. Process validation helps ensure a process consistently produces products meeting specifications and quality attributes. It involves understanding and controlling sources of variation. Validation protocols, reports, teams, and the lifecycle are also reviewed to explain how process validation is planned and documented.
Process validation involves three key stages:
1) Process design to define the commercial manufacturing process based on development and scale-up.
2) Process qualification to evaluate the design and determine if reproducible commercial manufacturing is possible.
3) Continued process verification to ensure the process remains in control during routine production through monitoring and adjustment.
Quality control is an important part of quality management that aims to identify errors and ensure products and services meet requirements. Key aspects of quality control include inspection at receiving, in-process, and final stages to check for defects. Tools like gauges and measuring equipment are used to inspect for conformance to specifications. For services, important quality characteristics are identified and measured through checklists and data collection. Approaches like HACCP focus on preventing hazards rather than final inspection. Project quality management involves quality planning, assurance, and control activities to satisfy quality standards. Overall, quality control aims to eliminate errors and improve processes.
The Validation Master Plan (VMP) outlines the company's approach to validation. It defines responsibilities, schedules, and documentation requirements for qualification of facilities, equipment, and processes. The VMP ensures management understands validation needs and the validation team understands their tasks. Key elements include qualification protocols for equipment operational performance and process validation protocols to demonstrate processes consistently meet requirements. The VMP is a living document that is updated with changes to facilities, equipment, or processes.
The Validation Master Plan (VMP) outlines the company's approach to validation. It defines responsibilities, schedules, and documentation requirements for qualification of facilities, equipment, and processes. The VMP ensures management understands validation needs and the validation team understands their tasks. Key elements include qualification of equipment and facilities, process validation, cleaning validation, change control procedures, and periodic revalidation. Qualification includes design, installation, operational, and performance qualification to confirm equipment and facilities operate as intended. Process validation demonstrates manufacturing processes consistently produce products meeting specifications. The VMP helps regulatory inspectors evaluate the company's validation program.
Validation of pharmaceutical dosage formanurag chanda
This document discusses process validation in the pharmaceutical industry. It defines process validation as collecting and evaluating data throughout production to ensure a process can consistently deliver quality products. The objectives of process validation include increasing confidence in quality systems and product quality. There are different types of validation including prospective, retrospective, and periodic revalidation. A successful validation requires establishing operating parameters, demonstrating control of the process, and monitoring the output to ensure it meets specifications. Validation protocols and master validation plans provide the framework and documentation for validation activities.
The all the content in this profile is completed by the teachers, students as well as other health care peoples.
thank you, all the respected peoples, for giving the information to complete this presentation.
this information is free to use by anyone.
Patient compliance with medical adviceRavish Yadav
The all the content in this profile is completed by the teachers, students as well as other health care peoples.
thank you, all the respected peoples, for giving the information to complete this presentation.
this information is free to use by anyone.
The all the content in this profile is completed by the teachers, students as well as other health care peoples.
thank you, all the respected peoples, for giving the information to complete this presentation.
this information is free to use by anyone.
This document defines osmosis and osmotic pressure, and describes how osmotic systems utilize these principles for controlled drug delivery. It discusses the basic components of osmotic systems, including drugs, osmotic agents, semi-permeable membranes, and plasticizers. It also describes various types of osmotic systems for both oral and implantable drug delivery, including elementary osmotic pumps, push-pull osmotic pumps, and implantable mini-osmotic pumps. The document provides equations to describe drug release from these systems driven by osmotic pressure.
The document discusses opioid analgesics and their mechanisms of action. It notes that the body has an endogenous analgesic system centered in the brainstem that is stimulated by opioids. Opioids work by binding to mu, delta, and kappa receptors in the brain and spinal cord, inhibiting pain signal transmission. Several opioid analgesics are described, including morphine, codeine, heroin, fentanyl, and methadone. Tolerance, side effects, metabolism, and antagonists are also discussed. The future of opioid analgesics is seen to involve further study of the kappa receptor and endogenous opioid peptides to develop safer drugs.
Infrared spectrum / infrared frequency and hydrocarbonsRavish Yadav
This document provides information about infrared (IR) spectroscopy and analyzing IR spectra of different functional groups. It discusses:
1. The conditions required for IR absorption and the division of the IR spectrum into the functional group and fingerprint regions.
2. The characteristic IR absorptions of common functional groups like alkanes, alkenes, alkynes, alcohols, phenols, ethers, aldehydes, ketones, carboxylic acids, esters, amides, amines, and aromatics. Specific examples and their spectra are provided.
3. Factors that affect IR frequencies, such as bond strength, mass of atoms, resonance, conjugation, and hydrogen bonding.
Neurotransmitters are endogenous chemicals that transmit signals between neurons. The major categories are small-molecule neurotransmitters like acetylcholine and amino acids, and large peptides. They act on ligand-gated ion channels or G protein-coupled receptors. After release, they are typically removed from the synapse by reuptake back into the presynaptic neuron or breakdown by enzymes. Examples include acetylcholine, which activates nicotinic and muscarinic receptors, and glutamate, the main excitatory neurotransmitter in the brain. GABA is the primary inhibitory neurotransmitter and binds GABAA/B/C receptors. Neuropeptides are longer amino acid chains that modulate synaptic transmission.
Narcotic drugs and psychotropic substances act, 1985Ravish Yadav
The all the content in this profile is completed by the teachers, students as well as other health care peoples.
thank you, all the respected peoples, for giving the information to complete this presentation.
this information is free to use by anyone.
The all the content in this profile is completed by the teachers, students as well as other health care peoples.
thank you, all the respected peoples, for giving the information to complete this presentation.
this information is free to use by anyone.
The all the content in this profile is completed by the teachers, students as well as other health care peoples.
thank you, all the respected peoples, for giving the information to complete this presentation.
this information is free to use by anyone.
Medicinal and toilet preparations (excise duties) act, 1995 and rules, 1956Ravish Yadav
The all the content in this profile is completed by the teachers, students as well as other health care peoples.
thank you, all the respected peoples, for giving the information to complete this presentation.
this information is free to use by anyone.
Lipids can be classified by their structure as simple lipids like fats and oils or complex lipids like phospholipids. They can also be classified based on whether they undergo hydrolysis in alkaline solutions. Lipids are made up of fatty acids and glycerol, forming triglycerides. Fats are usually saturated while oils contain some unsaturated fatty acids. Waxes differ from fats and oils in that they are esters of long-chain alcohols and fatty acids with higher melting points. Lipids serve important functions and have many applications, such as in soaps, foods, and cosmetics.
The all the content in this profile is completed by the teachers, students as well as other health care peoples.
thank you, all the respected peoples, for giving the information to complete this presentation.
this information is free to use by anyone.
The all the content in this profile is completed by the teachers, students as well as other health care peoples.
thank you, all the respected peoples, for giving the information to complete this presentation.
this information is free to use by anyone.
The document summarizes the tricarboxylic acid (TCA) cycle, also known as the Krebs cycle or citric acid cycle. It discusses that the TCA cycle involves the oxidation of acetyl-CoA to carbon dioxide and water and is the final common pathway for carbohydrates, fats, and amino acids. The cycle occurs in the mitochondrial matrix and generates energy in the form of NADH and FADH2 that are used in the electron transport chain to produce ATP. Key enzymes and reactions in the cycle are described, including the generation of citrate, isocitrate, alpha-ketoglutarate, succinyl-CoA, fumarate, oxaloacetate
The all the content in this profile is completed by the teachers, students as well as other health care peoples.
thank you, all the respected peoples, for giving the information to complete this presentation.
this information is free to use by anyone.
Anti mycobacterial drugs (tuberculosis drugs)Ravish Yadav
This document discusses anti-mycobacterial drugs used to treat tuberculosis. It begins by describing tuberculosis and how it is caused by the bacterium Mycobacterium tuberculosis. First-line drugs to treat tuberculosis are listed as isoniazid, rifampin, pyrazinamide, ethambutol, and streptomycin. Each drug's mechanism of action and potential resistance issues are then explained individually. Second-line drugs discussed include ethionamide, capreomycin, cycloserine, aminosalicylic acid, and fluoroquinolones. Common adverse drug reactions are also outlined.
This document provides information on various anti-malarial agents. It discusses the life cycle of Plasmodium parasites and the four species that cause malaria in humans. It then describes various classes of anti-malarial drugs including those derived from natural sources like cinchona alkaloids and artemisinin, as well as synthetic agents like chloroquine, primaquine, mefloquine, and antifolate drugs. For each class, it provides details on examples, mechanisms of action, structure-activity relationships, resistance issues, and pharmacological properties. The document aims to comprehensively cover the major therapeutic options available to treat malaria.
The all the content in this profile is completed by the teachers, students as well as other health care peoples.
thank you, all the respected peoples, for giving the information to complete this presentation.
this information is free to use by anyone.
The all the content in this profile is completed by the teachers, students as well as other health care peoples.
thank you, all the respected peoples, for giving the information to complete this presentation.
this information is free to use by anyone.
Temple of Asclepius in Thrace. Excavation resultsKrassimira Luka
The temple and the sanctuary around were dedicated to Asklepios Zmidrenus. This name has been known since 1875 when an inscription dedicated to him was discovered in Rome. The inscription is dated in 227 AD and was left by soldiers originating from the city of Philippopolis (modern Plovdiv).
🔥🔥🔥🔥🔥🔥🔥🔥🔥
إضغ بين إيديكم من أقوى الملازم التي صممتها
ملزمة تشريح الجهاز الهيكلي (نظري 3)
💀💀💀💀💀💀💀💀💀💀
تتميز هذهِ الملزمة بعِدة مُميزات :
1- مُترجمة ترجمة تُناسب جميع المستويات
2- تحتوي على 78 رسم توضيحي لكل كلمة موجودة بالملزمة (لكل كلمة !!!!)
#فهم_ماكو_درخ
3- دقة الكتابة والصور عالية جداً جداً جداً
4- هُنالك بعض المعلومات تم توضيحها بشكل تفصيلي جداً (تُعتبر لدى الطالب أو الطالبة بإنها معلومات مُبهمة ومع ذلك تم توضيح هذهِ المعلومات المُبهمة بشكل تفصيلي جداً
5- الملزمة تشرح نفسها ب نفسها بس تكلك تعال اقراني
6- تحتوي الملزمة في اول سلايد على خارطة تتضمن جميع تفرُعات معلومات الجهاز الهيكلي المذكورة في هذهِ الملزمة
واخيراً هذهِ الملزمة حلالٌ عليكم وإتمنى منكم إن تدعولي بالخير والصحة والعافية فقط
كل التوفيق زملائي وزميلاتي ، زميلكم محمد الذهبي 💊💊
🔥🔥🔥🔥🔥🔥🔥🔥🔥
How to Manage Reception Report in Odoo 17Celine George
A business may deal with both sales and purchases occasionally. They buy things from vendors and then sell them to their customers. Such dealings can be confusing at times. Because multiple clients may inquire about the same product at the same time, after purchasing those products, customers must be assigned to them. Odoo has a tool called Reception Report that can be used to complete this assignment. By enabling this, a reception report comes automatically after confirming a receipt, from which we can assign products to orders.
THE SACRIFICE HOW PRO-PALESTINE PROTESTS STUDENTS ARE SACRIFICING TO CHANGE T...indexPub
The recent surge in pro-Palestine student activism has prompted significant responses from universities, ranging from negotiations and divestment commitments to increased transparency about investments in companies supporting the war on Gaza. This activism has led to the cessation of student encampments but also highlighted the substantial sacrifices made by students, including academic disruptions and personal risks. The primary drivers of these protests are poor university administration, lack of transparency, and inadequate communication between officials and students. This study examines the profound emotional, psychological, and professional impacts on students engaged in pro-Palestine protests, focusing on Generation Z's (Gen-Z) activism dynamics. This paper explores the significant sacrifices made by these students and even the professors supporting the pro-Palestine movement, with a focus on recent global movements. Through an in-depth analysis of printed and electronic media, the study examines the impacts of these sacrifices on the academic and personal lives of those involved. The paper highlights examples from various universities, demonstrating student activism's long-term and short-term effects, including disciplinary actions, social backlash, and career implications. The researchers also explore the broader implications of student sacrifices. The findings reveal that these sacrifices are driven by a profound commitment to justice and human rights, and are influenced by the increasing availability of information, peer interactions, and personal convictions. The study also discusses the broader implications of this activism, comparing it to historical precedents and assessing its potential to influence policy and public opinion. The emotional and psychological toll on student activists is significant, but their sense of purpose and community support mitigates some of these challenges. However, the researchers call for acknowledging the broader Impact of these sacrifices on the future global movement of FreePalestine.
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...TechSoup
Whether you're new to SEO or looking to refine your existing strategies, this webinar will provide you with actionable insights and practical tips to elevate your nonprofit's online presence.
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.pptHenry Hollis
The History of NZ 1870-1900.
Making of a Nation.
From the NZ Wars to Liberals,
Richard Seddon, George Grey,
Social Laboratory, New Zealand,
Confiscations, Kotahitanga, Kingitanga, Parliament, Suffrage, Repudiation, Economic Change, Agriculture, Gold Mining, Timber, Flax, Sheep, Dairying,
How to Download & Install Module From the Odoo App Store in Odoo 17Celine George
Custom modules offer the flexibility to extend Odoo's capabilities, address unique requirements, and optimize workflows to align seamlessly with your organization's processes. By leveraging custom modules, businesses can unlock greater efficiency, productivity, and innovation, empowering them to stay competitive in today's dynamic market landscape. In this tutorial, we'll guide you step by step on how to easily download and install modules from the Odoo App Store.
3. Validation
• Validation is an essential part of GMP, and an element of QA
• Basic principles include:
– Safety, quality and efficacy of products
– Built into the product – as it cannot be
"inspected or tested into a product"
– Critical steps in the process need to be
validated
• Need for confidence that the product will consistently meet
predetermined specifications and attributes
4. Validation
Documentation associated with validation:
• SOPs
• Specifications
• Validation Master Plan (VMP)
• Qualification protocols and reports
• Validation protocols and reports
5. Validation
Validation work requires considerable resources such as:
• Time:
– work is subject to rigorous time schedules
• Money:
– may need specialized personnel and expensive technology
• People:
– collaboration of experts from various disciplines
– a multidisciplinary team, comprising quality assurance,
engineering, production, quality control (other disciplines,
depending on the product and process to be validated)
6. • DEFINITION-
• Validation is a key process for effective quality
assurance.
• “Validation is establishing documented evidence which
provides a high degree of assurance that a specific
process or equipment will consistently produce a
product or result meeting its predetermined
specifications and quality attributes.”
7. 7
The major reasons for validation are:
• Quality assurance:
Validation checks the accuracy and reliability of a system
or a process to meet the predetermined criteria. A successful
validation provides high degree of assurance that a consistent
level of quality is maintained in each unit of the finished
product from one batch to another batch.
• Economics:
Due to successful validation, there is a decrease in sampling
and testing procedures and there are less number of product
rejections and retesting. This leads to cost-saving benefits.
9. Validation
Qualification and Validation
• Qualification and validation are essentially components of the
same concept
• The term qualification is normally used for equipment, utilities and
systems
• The term validation is normally used for processes
• In this sense, qualification is part of validation
10. Validation
Validation: Approaches to validation
• Two basic approaches:
1.Evidence obtained through testing
(prospective and concurrent validation), and
2.Analysis of accumulated (historical) data
(retrospective validation)
• Whenever possible, prospective validation is preferred.
• Retrospective validation is no longer encouraged
• Retrospective validation is not applicable to sterile products
11. • Prospective validation:
-Conducted prior to market the product.
- Documented evidence which provides a high degree of
assurances that a specific process or equipment will
consistently produce a product meeting its predetermined
specifications and quality attributes.
• Concurrent validation:
Based on information generated during actual implementation
of the process.
Establishing documented evidence that the process is in a
state of control during the actual implementation of the
process. This normally performed by conducting in- process
testing.
Type of Process Validation-
12. • Retrospective validation:
All the processes and subsystems should be validated ,which
have been used for the production of batches of numerical data
of both process and the end product testing of which are
included in retrospective validation.
13. Validation
Validation: Approaches to validation (2)
• Both prospective and concurrent validation, may include:
– extensive product testing, which may involve extensive sample
testing (with the estimation of confidence limits for individual
results) and the demonstration of intra- and inter-batch
homogeneity;
– simulation process trials;
– challenge/worst case tests, which determine the robustness of
the process; and
– control of process parameters being monitored during normal
production runs to obtain additional information on the
reliability of the process.
14. Validation
Scope of validation
• Validation requires an appropriate and sufficient infrastructure including:
– organization, documentation, personnel and finances
• Involvement of management and quality assurance personnel
• Personnel with appropriate qualifications and experience
• Extensive preparation and planning before validation is performed
• A specific programme for validation activities in place
• Validation done in a structured way according to documentation including
procedures and protocols.
15. Validation
Scope of validation
• Validation should be performed:
– for new premises, equipment, utilities and systems, and
processes and procedures;
– at periodic intervals; and
– when major changes have been made.
• Validation in accordance with written protocols.
• A written report on the outcome to be produced.
• Validation over a period of time, e.g.
– at least three consecutive batches (full production scale) to
demonstrate consistency. (Worst case situations should be
considered.)
16. Validation
Scope of validation
• Distinction between in-process controls and validation
– In-process tests (performed during the manufacture of each
batch; their objective is to monitor the process continuously)
• Demonstrate suitability for new manufacturing formula or method
• Process, materials and equipment to prove consistent yield of a
product of the required quality
• Manufacturers to identify what validation work is needed
• Significant changes (facilities, equipment, processes) - should be
validated
• Risk assessment approach used to determine the scope and extent of
validation needed
17. Validation
Qualification
• Qualification should be completed before process validation is
performed
• A logical, systematic process followed
• Start from the design phase of the premises, equipment, utilities
and equipment
• Major equipment and critical utilities and systems normally
require IQ, OQ and PQ
18. Validation
Qualification
• Some equipment, utilities and systems require only IQ and OQ as
the correct operation could be considered to be a sufficient
indicator of its performance
• The equipment, utility and system should then be maintained,
monitored and calibrated according to a regular schedule
19. Validation
• Calibration: The set of operations that establish, under specified
conditions, the relationship between values indicated by an
instrument or system for measuring (for example, weight,
temperature and pH), recording and controlling, or the values
represented by a material measure, and the corresponding known
values of a reference standard. Limits for acceptance of the results
of measuring should be established.
20. Validation
Calibration and verification
• Performed at regular intervals
• Responsible personnel with appropriate qualifications and training
• Calibration programme available including information, e.g.
– calibration standards and limits, responsible
persons, calibration intervals, records and
actions to be taken when necessary
21. Validation
Calibration and verification
• Traceability to standards used
–(e.g. national, regional or international
standards)
• Calibrated equipment, instruments and other devices to be
labelled, coded or otherwise identified
–indicate status of calibration and recalibration
due date
• If not used for a certain period of time
–function and calibration status to be verified
–shown to be satisfactory before use
22. Validation
• Suitable labels indicate
calibration status
• Traceability, e.g.
– Instrument
– Date
– Personnel
– Standard
– Range and conditions as
appropriate
24. Validation
Validation Master Plan (VMP)
• Contains key elements of the validation programme.
• Concise, clear, contain at least:
– a validation policy
– organizational structure of validation activities
– summary of facilities, systems, equipment and
processes validated (and to be validated)
– documentation format (e.g. protocol and report)
– planning and scheduling
– change control and references to existing
documents
25. Validation
Qualification and validation protocols
• Describe the study to be performed and include as a minimum:
– the objectives of the study
– the site of the study
– the responsible personnel
– description of SOPs to be followed
– equipment to be used
– standards and criteria for the products and
processes
– the type of validation
26. Validation
Qualification and validation protocols (2)
• Protocol contents (2):
– the processes and/or parameters
– sampling, testing and monitoring
requirements
– predetermined acceptance criteria for
drawing conclusions
• Description (how results will be analysed)
• Protocol approved prior to use - changes approved prior to
implementation of the change
27. Validation
Qualification and validation reports
• Written reports on the qualification and validation performed
• Reflect protocols followed and include at least:
–title and objective of the study; reference to
the protocol; details of material
–equipment, programmes and cycles used;
procedures and test methods
• Results evaluated, analysed and compared against the pre-
determined acceptance criteria
28. Validation
Qualification and validation reports (2)
• The results should meet the acceptance criteria
• Deviations and out-of-limit results should be investigated. If these
are accepted, this should be justified. Where necessary further
studies should be performed
• Responsible departments and QA to approve completed report,
including the conclusion
29. Validation
Qualification stages
• There are four stages of qualification:
– design qualification (DQ);
– installation qualification (IQ);
– operational qualification (OQ); and
– performance qualification (PQ).
• All SOPs for operation, maintenance and calibration should be
prepared during qualification
• Training provided and records maintained
30. Validation
Design qualification: Provides documented evidence that the design
specifications were met
Installation qualification: Provides documented evidence that the
installation was complete and satisfactory
• During IQ:
– Purchase specifications, drawings, manuals,
spare parts lists and vendor details should be
verified
– Control and measuring devices should be
calibrated
31. Validation
Operational qualification: Provides documented evidence that
utilities, systems or equipment and all its components operate in
accordance with operational specifications
• Demonstrate satisfactory operation over the normal operating
range as well as at the limits of its operating conditions (including
worst case conditions)
• Operation controls, alarms, switches, displays and other
operational components should be tested
32. Validation
Performance qualification: Provides documented evidence that
utilities, systems or equipment and all its components can
consistently perform in accordance with the specifications under
routine use
• Test results collected over a suitable period of time to prove
consistency
33. Validation
Requalification
• In accordance with a defined schedule
• Frequency to be determined (e.g. on the basis of factors such as
the analysis of results relating to calibration, verification and
maintenance)
• Periodic and after changes
– e.g. changes to utilities, systems, equipment;
maintenance work; and movement
• Part of change control procedure
34. Validation
Revalidation
• Processes and procedures - to ensure that they remain capable of
achieving the intended results
• Periodic revalidation, as well as revalidation after changes
• In accordance with a defined schedule
• Frequency and extent determined using a risk-based approach
together with a review of historical data
35. Validation
Periodic revalidation
• To assess process changes that may occur gradually over a period
of time, or because of wear of equipment
• Consideration given to:
– master formulae and specifications
– SOPs
– records (e.g. of calibration, maintenance and
cleaning)
– analytical methods
36. Validation
Revalidation after change
• After change that could have an effect on the process, procedure,
quality of the product and/or the product characteristics.
(Considered as part of the change control procedure.)
• Extent depends on the nature and significance of the change(s)
• Changes should not adversely affect product quality or process
characteristics
37. Validation
Changes requiring revalidation should
be defined in the validation plan and
may include:
– changes in starting materials
– change of starting material manufacturer
– transfer of processes to a different site
– changes of primary packaging material
– changes in the manufacturing process
– changes in the equipment
– production area and support system changes
– appearance of negative quality trends
– appearance of new findings based on current
knowledge
– support system changes
– e.g. including physical properties, such as density,
viscosity or particle size distribution that may affect
the process or product
– e.g. change of facilities and installations which
influence the process
– e.g. substituting plastic for glass
– e.g. mixing times or drying temperatures
– e.g. addition of automatic detection systems,
installation of new equipment, major revisions to
machinery or apparatus and breakdowns
– e.g. rearrangement of areas, or a new water
treatment method
– e.g. new technology
38. Validation
Revalidation after change (continuation)
• Changes of equipment which involve the replacement of
equipment on a “like-for-like” basis would not normally require a
revalidation
• For example, installation of a new centrifugal pump to replace an
older model would not necessarily require revalidation
39. Validation
Change control
• SOP followed - as changes may have an impact on a qualified
utility, system or piece of equipment, and a validated process
and/or procedure
• Describe the actions to be taken, including the need for and extent
of qualification or validation
• Changes should be formally requested, documented and approved
before implementation
• Records should be maintained
40. Validation
Personnel
• Demonstrate that personnel are appropriately qualified, where
relevant
• These include for example:
– laboratory analysts;
– personnel following critical procedures;
– personnel doing data entry in computerized
systems; and
– risk assessors.